Alterations in the retinoblastoma pathway of cell cycle control in parathyroid tumors

I Szijan1, I Orlow, V Dalamon

  • 1Genética y Biología Molecular, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, 1113 Buenos Aires, Argentina.

Oncology Reports
|February 15, 2000
PubMed

Insights

Alterations in the pRB pathway, including the retinoblastoma gene (RB) and cyclin D1 (Cyc D1), are more common in aggressive parathyroid tumors than adenomas. These findings suggest potential tumor markers for parathyroid neoplasms.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Proto-oncogene and tumor suppressor gene mutations are linked to cancer development.
  • Parathyroid tumors may exhibit retinoblastoma gene (RB) deletions and cyclin D1 (Cyc D1) overexpression.

Purpose of the Study:

  • To investigate alterations in the pRB pathway components in parathyroid adenomas and aggressive tumors.
  • To analyze the expression patterns of pRB, Cyc D1, and p16/INK4A in these tumors.

Main Methods:

  • Analysis of paired normal and tumor DNA from 6 parathyroid adenomas and 5 aggressive tumors for loss of heterozygosity (LOH) at the RB locus.
  • Immunohistochemical analysis of pRB, Cyc D1, and p16 expression in tumor samples.

Main Results:

  • RB LOH was detected in one adenoma and one aggressive tumor.
  • Undetectable pRB was observed in 4 out of 5 aggressive tumors, while present in all adenomas.
  • Cyc D1 was overexpressed in 3 out of 4 aggressive tumors but undetectable in adenomas. p16 expression was found in only one aggressive tumor.

Conclusions:

  • Alterations in the pRB pathway are more prevalent in aggressive parathyroid neoplasms.
  • Further research into these cell cycle regulators may identify potential tumor markers for parathyroid tumors.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Parathyroid Glands00:59

The Parathyroid Glands

The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...